Back to Journals

Neuropsychiatric Disease and Treatment


Dr Pinder

Pharma, Independent Pharma Consultant, United Kingdom

Dr Pinder

Editor-in-Chief:  Dr Roger M. Pinder, PhD, DSc

Dr Pinder is an independent pharma consultant based in the city of York in the UK. He advises and consults worldwide to several pharmaceutical and venture capital organizations. He is founding editor of Neuropsychiatric Disease and Treatment and of the International Journal of Wine Research. He has served as president and secretary of the International Society for Affective Disorders (ISAD), and as treasurer and councillor of the International College of Neuropsychopharmacology (CINP).

Educated in the UK and the USA at the universities of Hull and Virginia, Dr Pinder holds doctoral degrees in medicinal chemistry (PhD) and neuropsychopharmacology (DSc). He is a fellow of the British Pharmacological Society, the British Association for Psychopharmacology, the European (ECNP) and the International Colleges of Neuropsychopharmacology (CINP), and of ISAD, and serves on the editorial board of Medicinal Chemistry Research. His professional research interests include cardiovascular and CNS pharmacology and therapeutics, with a special emphasis on depressive disorders, anti-depressants and the health benefits of wine. He is a regular speaker and chair at international congresses, and has published five books and more than 250 review and research articles.

After a long career in R&D and medical affairs management in the international pharmaceutical industry, DrPinder is now a board member of a number of start-up pharmaceutical companies.


Dr Chen

Office of Clinical Research Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, China (PRC)

Dr Chen

Associate Editor: Dr. Jun Chen   M.D., Ph.D.

Dr. Jun Chen is the director of the office for Clinical Research Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine(SMHC). He is serving as a Board Member/Asia for the International Society for Bipolar Disorders(ISBD), Fellow for the Pacific Rim College of Psychiatrists(PRCP), Secretary for the Chinese Society of Psychiatry(CSP), Vice Chairman for the Youth Committee of the CSP, and Committee member for the Chinese Psychiatrist Association(CPA).
 
Educated in China and USA, he received his M.D./Ph.D. degree in psychiatry at Shanghai Jiao Tong University School of Medicine in 2009. In 2010, he got the early-career psychiatrist research fellow funding from the World Psychiatric Association. After that, he worked and studied with Prof. Joseph R. Calabrese and Dr. Keming Gao in the Mood Disorders Program in Case Western Reserve University School of Medicine for one year. From 2014, Dr. Chen joined the APEC workshop to promote innovative collaborations in mental health, to work together with professionals from APEC.
 
Dr. Chen's research focuses on the phenomenon and treatment of bipolar disorder and treatment-resistant depression, which including clinical trial, cognition function and neuroimaging.


Professor Kishi

Department of Psychiatry, Fujita Health University School of Medicine, Japan

Professor Kishi

Associate Editor - Japan: Dr Taro Kishi

Dr. Kishi has been practicing at the Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan, since 2002. In 2010 and 2011, he spent two years as a postdoctoral research fellow at the Zucker Hillside Hospital in New York. Dr. Kishi is a senior lecturer at the Department of Psychiatry, Fujita Health University School of Medicine. Dr. Kishi has been performing a series of clinical trials for the treatment of schizophrenia and mood disorder. His research focus is also evidence-based medicine in schizophrenia and mood disorder with a focus on meta-analyses. Moreover, He has a research interest in psychiatric genetics, pharmacogenetics, compliance enhancement strategies and medical decision making. He has authored/co-authored more than 120 articles.


Dr Ning

Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University, China (PRC)

Dr Ning

Associate Editor: Yuping Ning

Dr. Yuping Ning is director of the affiliated brain hospital of Guangzhou Medical University P.R.C. She is professor in neuropsychiatry and supervisor of PH.D students. She holds some positions such as member of Chinese Society of Psychiatry, Chairman of Guangdong Society of Psychiatry, member of standing committee of Guangdong Society of Neurology, etc. From 1986 to 1992, she educated in XiangYa Medical college and got MD degree there. From 1992 to 1997, she practised psychiatry in Guangzhou Brain Hospital. From 1997 to 2003, she practised and pursuited her PHD in department of Neurology, Sun Yat-Sen medical university. Her research interests are in neurodegenerative diseases(AD and PD) and depression. As a visiting scholar, she performed genetic study in Parkinson disease in Juntendo University Japan. She has published 130 papers so far.


Editorial Board

Hojjat Adeli, Professor, The Ohio State University, Columbus, OH, USA

Kristian Barlinn, Department of Neurology, University Hospital Carl Gustav Carus, Dresden, Germany

Marlene Oscar Berman, Professor of Psychiatry, Neurology, Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA

Sandra Chan, Associate Professor, Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong

Lin Chen, MD, Ph.D., Neurosurgeon, Department of Neurosurgery, Tsinghua University Yuquan Hospital, People’s Republic of China

Wai-Tong Chien, Professor, Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong.

Francesco Craig, Child Neuropsychiatry Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”, Italy

Anthony S. David, Professor of Cognitive Neuropsychiatry, Vice Dean, Academic Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, Kings College, London, UK

Andrea Fagiolini, Professor of Psychiatry, Chairman, Department of Molecular Medicine, University of Siena, Italy

Mike Isaac, Consultant and Hon Senior Lecturer in Psychiatry, South London & Maudsley NHS FT and University of London, UK

Andrey Iznak, Professor, Mental Health Research Centre, Moscow, Russia

Sidney H Kennedy, Professor and Arthur Sommer Rotenberg Chair in Depression and Suicide Studies, St. Michael’s Hospital and University of Toronto, Canada

Firas Kobeissy, Asst Rsrch Prof, Assoc Scientific Dir of Psychoproteomics & Nanotechnology Rsrch Ctr, Dept of Psychiatry, The Evelyn F & William L McKnight Brain Institute, University of Florida, Gainesville, FL, USA

Michael Krausz, UBC-Providence Leadership Chair for Addiction Research, Professor of Psychiatry, Director Addiction Psychiatry, Institute of Mental Health, The University of British Columbia, Vancouver, BC, Canada

John S Markowitz, Professor, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, FL, USA

Peter R. Martin, M.D., Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, Vanderbilt Psychiatric Hospital, Vanderbilt University School of Medicine, Nashville, TN, USA

Julien Mendlewicz, Professor, Free University of Brussels, Brussels, Belgium

Shinichi Mitsui, Professor, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan

Zoran M Pavlovic MD, Psychiatry & Neurology Consultant to Pharma/Biotech companies and CROs, Belgrade, Serbia

George Perry, Chief Scientist, Brain Health Consortium, Professor of Biology and Chemistry, College of Sciences, University of Texas at San Antonio, San Antonio, TX, USA. Research interests: Alzheimer’s disease, oxidative stress, metabolism, mitochondria, redox chemistry, iron, copper.

Steven Potkin, Professor, University of California, Irvine, USA

Norman Sartorius, MD, PhD, FRCpsych, President, Association for the Improvement of Mental Health Programmes, Switzerland

Alessandro Serretti, MD, PhD, Department of Biomedical and NeuroMotor Sciences, University of Bologna, Italy

Haowei Shen, Ph.D., Physiology & Pharmacology, Ningbo University School of Medicine, Beijing, People's Republic of China

PD Dr. Timo Siepmann, Neurologist, Site Director, Principles and Practice of Clinical Research (Harvard TH Chan School of Public Health); Director, Master's Program in Clinical Research (Dresden International University), Department of Neurology University Hospital Carl Gustav Carus Dresden, Germany

Edoardo Spina, Professor of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Eduard Vieta, Professor and Director of Research, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, Spain

Ng Beng Yeong, Consultant Psychiatrist, Mount Elizabeth Medical Centre, Singapore

Nathan Zasler, CEO & Medical Director for Concussion Care Centre of Virginia, Ltd., and CEO & Medical Director for Tree of Life Services, Inc.; Clinical Professor, Department of PM&R, Virginia Commonwealth University, and Clinical Associate Professor, Department of PM&R, University of Virginia, Charlottesville, Virginia, USA